KPX Lifescience.Co.Ltd (114450) - Total Liabilities

Latest as of September 2025: ₩15.22 Billion KRW ≈ $10.31 Million USD

Based on the latest financial reports, KPX Lifescience.Co.Ltd (114450) has total liabilities worth ₩15.22 Billion KRW (≈ $10.31 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore KPX Lifescience.Co.Ltd operating cash flow efficiency to assess how effectively this company generates cash.

KPX Lifescience.Co.Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how KPX Lifescience.Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 114450 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

KPX Lifescience.Co.Ltd Competitors by Total Liabilities

The table below lists competitors of KPX Lifescience.Co.Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Andromeda Metals Ltd AU:ADN	Australia	AU$2.27 Million
BPL Limited NSE:BPL	India	Rs3.28 Billion
Shaftesbury Capital PLC LSE:SHC	UK	GBX1.31 Billion
International Public Partnership LSE:INPP	UK	GBX11.11 Million
DIAMINES AND CHEMICALS ORD (BSE) NSE:DIAMINESQ	India	Rs232.88 Million
Karolinska Development AB ser. B ST:KDEV	Sweden	Skr8.34 Million
Xavis Co. Ltd KQ:254120	Korea	₩11.92 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down KPX Lifescience.Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 114450 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.90	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.43	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.30	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how KPX Lifescience.Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for KPX Lifescience.Co.Ltd (2014–2024)

The table below shows the annual total liabilities of KPX Lifescience.Co.Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩9.22 Billion ≈ $6.25 Million	+17.14%
2023-12-31	₩7.87 Billion ≈ $5.34 Million	-19.59%
2022-12-31	₩9.79 Billion ≈ $6.64 Million	-37.54%
2021-12-31	₩15.68 Billion ≈ $10.63 Million	+36.63%
2020-12-31	₩11.48 Billion ≈ $7.78 Million	-0.53%
2019-12-31	₩11.54 Billion ≈ $7.82 Million	+12.43%
2018-12-31	₩10.26 Billion ≈ $6.95 Million	-5.62%
2017-12-31	₩10.87 Billion ≈ $7.37 Million	-29.38%
2016-12-31	₩15.39 Billion ≈ $10.43 Million	+50.15%
2015-12-31	₩10.25 Billion ≈ $6.95 Million	-31.21%
2014-12-31	₩14.90 Billion ≈ $10.10 Million	--

About KPX Lifescience.Co.Ltd

KQ:114450 Korea Pharmaceuticals

Market Cap

$29.38 Million

₩43.35 Billion KRW

Market Cap Rank

#23772 Global

#1714 in Korea

Share Price

₩2890.00

Change (1 day)

-1.37%

52-Week Range

₩1589.00 - ₩4065.00

All Time High

₩20587.50